Takeda’s Agreement with Adium Pharma

Marval O’Farrell Mairal advised Takeda on the transaction Takeda Pharmaceutical Company Limited  (TSE:4502/NYSE:TAK) has entered into an agreement to divest a selection of non-core products from the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

CLEAR’s Acquisition of Whyline

Fenwick and Marval, O’Farrell & Mairal represented CLEAR on the deal. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and Mitrani, Caballero & Ruiz Moreno advised Whyline....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Blockchain.com’s Acquisition of SeSocio

Marval O’Farrell Mairal advised Blockchain.com on the transaction. Pérez Alati, Grondona, Benites & Arntsen advised SeSocio. Blockchain.com executed the acquisition of  Argentinian company SeSocio. Blockchain.com accelerates its rapidly...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here